159 related articles for article (PubMed ID: 36575421)
1. IMNI PRECISION trial protocol: a phase II, open-label, non-inferior randomized controlled trial of tailoring omission of internal mammary node irradiation for early-stage breast cancer.
Qi WX; Cao L; Zheng S; Xu C; Cai R; Xu H; Cai G; Chen J
BMC Cancer; 2022 Dec; 22(1):1356. PubMed ID: 36575421
[TBL] [Abstract][Full Text] [Related]
2. POstmastectomy radioThErapy in Node-posiTive breast cancer with or without Internal mAmmary nodaL irradiation (POTENTIAL): a study protocol for a multicenter prospective phase III randomized controlled trial.
Zhao XR; Fang H; Tang Y; Hu ZH; Jing H; Liang L; Yan XN; Song YW; Jin J; Liu YP; Chen B; Tang Y; Qi SN; Li N; Lu NN; Men K; Hu C; Zhang YH; Li YX; Wang SL
BMC Cancer; 2021 Nov; 21(1):1185. PubMed ID: 34742270
[TBL] [Abstract][Full Text] [Related]
3. Effect of Elective Internal Mammary Node Irradiation on Disease-Free Survival in Women With Node-Positive Breast Cancer: A Randomized Phase 3 Clinical Trial.
Kim YB; Byun HK; Kim DY; Ahn SJ; Lee HS; Park W; Kim SS; Kim JH; Lee KC; Lee IJ; Kim WT; Shin HS; Kim K; Shin KH; Nam CM; Suh CO
JAMA Oncol; 2022 Jan; 8(1):96-105. PubMed ID: 34695841
[TBL] [Abstract][Full Text] [Related]
4. The optimal regional irradiation volume for breast cancer patients: A comprehensive systematic review and network meta-analysis of published studies.
Qi WX; Cao L; Xu C; Cai G; Chen J
Front Oncol; 2023; 13():1081201. PubMed ID: 36798812
[TBL] [Abstract][Full Text] [Related]
5. Internal mammary node irradiation improves 8-year survival in breast cancer patients: results from a retrospective cohort study in real-world setting.
Wang X; Luo J; Jin K; Chen X; Zhang L; Meng J; Zhang X; Zhang Z; Shao Z; Bazan JG; Guo X; Yang Z; Yu X
Breast Cancer; 2020 Mar; 27(2):252-260. PubMed ID: 31696449
[TBL] [Abstract][Full Text] [Related]
6. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
[TBL] [Abstract][Full Text] [Related]
7. DBCG-IMN: A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast Cancer.
Thorsen LB; Offersen BV; Danø H; Berg M; Jensen I; Pedersen AN; Zimmermann SJ; Brodersen HJ; Overgaard M; Overgaard J
J Clin Oncol; 2016 Feb; 34(4):314-20. PubMed ID: 26598752
[TBL] [Abstract][Full Text] [Related]
8. Utilization patterns and temporal trends of internal mammary nodal irradiation at a tertiary cancer center.
Misra S; Lee G; Maganti M; Koch CA
Breast Cancer Res Treat; 2020 Jul; 182(2):367-379. PubMed ID: 32474745
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant medial versus entire supraclavicular lymph node irradiation in high-risk early breast cancer (SUCLANODE): a protocol for a multicenter, randomized, open-label, phase 3 trial.
Zhang L; Mei X; Hu Z; Yu B; Zhang C; Li Y; Liu K; Ma X; Ma J; Chen X; Meng J; Shi W; Wang X; Mo M; Shao Z; Zhang Z; Yu X; Guo X; Yang Z
BMC Cancer; 2024 Jan; 24(1):49. PubMed ID: 38195438
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant radiotherapy of regional lymph nodes in breast cancer - a meta-analysis of randomized trials.
Budach W; Kammers K; Boelke E; Matuschek C
Radiat Oncol; 2013 Nov; 8():267. PubMed ID: 24225206
[TBL] [Abstract][Full Text] [Related]
11. OPTimizing Irradiation through Molecular Assessment of Lymph node (OPTIMAL): a randomized open label trial.
Algara López M; Rodríguez García E; Beato Tortajada I; Martínez Arcelus FJ; Salinas Ramos J; Rodríguez Garrido JR; Sanz Latiesas X; Soler Rodríguez A; Juan Rijo G; Flaquer García A
Radiat Oncol; 2020 Oct; 15(1):229. PubMed ID: 33008422
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant regional nodal irradiation did not improve outcomes in T1-2N1 breast cancer after breast-conserving surgery: A propensity score matching analysis of BIG02/98 and BCIRG005 trials.
Qi WX; Cao L; Xu C; Zhao S; Chen J
Breast; 2020 Feb; 49():165-170. PubMed ID: 31812892
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of the Addition of Internal Mammary Irradiation to Standard Adjuvant Radiation in Early-Stage Breast Cancer: A Systematic Review and Meta-Analysis.
Korzets Y; Levitas D; Grubstein A; Corn BW; Amir E; Goldvaser H
Curr Oncol; 2022 Sep; 29(9):6657-6673. PubMed ID: 36135092
[TBL] [Abstract][Full Text] [Related]
14. Internal Mammary Node Irradiation in Patients With Node-Positive Early Breast Cancer: Fifteen-Year Results From the Danish Breast Cancer Group Internal Mammary Node Study.
Thorsen LBJ; Overgaard J; Matthiessen LW; Berg M; Stenbygaard L; Pedersen AN; Nielsen MH; Overgaard M; Offersen BV;
J Clin Oncol; 2022 Dec; 40(36):4198-4206. PubMed ID: 35394824
[TBL] [Abstract][Full Text] [Related]
15. Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-III trial.
Henke G; Knauer M; Ribi K; Hayoz S; Gérard MA; Ruhstaller T; Zwahlen DR; Muenst S; Ackerknecht M; Hawle H; Fitzal F; Gnant M; Mátrai Z; Ballardini B; Gyr A; Kurzeder C; Weber WP
Trials; 2018 Dec; 19(1):667. PubMed ID: 30514362
[TBL] [Abstract][Full Text] [Related]
16. Long-term survival outcomes following internal mammary node irradiation in stage II-III breast cancer: results of a large retrospective study with 12-year follow-up.
Chang JS; Park W; Kim YB; Lee IJ; Keum KC; Lee CG; Choi DH; Suh CO; Huh SJ
Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):867-72. PubMed ID: 23747215
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Internal Mammary Nodes is Associated With Improved Overall Survival in Breast Cancer: A Meta-Analysis.
Shaikh PM; Mulherkar R; Khasawneh MT; Clump D; Hazard-Jenkins H; Hafez M; Vargo JA
Am J Clin Oncol; 2024 Feb; 47(2):81-87. PubMed ID: 37916961
[TBL] [Abstract][Full Text] [Related]
18. Can internal mammary lymph nodes irradiation bring survival benefits for breast cancer patients? A systematic review and meta-analysis of 12,705 patients in 12 studies.
Jia S; Liu Z; Zhang J; Zhao C; Zhu L; Kong J; Han H; Shang Y; Shen D; Duan X
Radiat Oncol; 2021 Feb; 16(1):42. PubMed ID: 33622345
[TBL] [Abstract][Full Text] [Related]
19. Regional Nodal Irradiation After Breast Conserving Surgery for Early HER2-Positive Breast Cancer: Results of a Subanalysis From the ALTTO Trial.
Gingras I; Holmes E; De Azambuja E; Nguyen DH; Izquierdo M; Anne Zujewski J; Inbar M; Naume B; Tomasello G; Gralow JR; Wolff AC; Harris L; Gnant M; Moreno-Aspitia A; Piccart MJ; Azim HA
J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376188
[TBL] [Abstract][Full Text] [Related]
20. Does internal mammary node irradiation affect treatment outcome in clinical stage II-III breast cancer patients receiving neoadjuv ant chemotherapy?
Kim KH; Noh JM; Kim YB; Chang JS; Keum KC; Huh SJ; Choi DH; Park W; Suh CO
Breast Cancer Res Treat; 2015 Aug; 152(3):589-99. PubMed ID: 26202053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
